Navigating supply chain disruptions: Key strategies for resilient logistics

Just when pharmaceutical supply chains had begun to recover from the chaos of the pandemic, companies are now faced with the threat of US tariffs and the ongoing investigation into the United States’ reliance on drug imports. Nick Fryer, vice president of marketing, Sheer Logistics discusses.

According to a recent survey, 90% of US biotech companies rely on imported components for at least half of their US Food and Drug Administration (FDA)-approved products. 94% of the survey respondents forecast an increase in manufacturing costs if tariffs are placed on imports from the…